# CDSCO

Type: organization

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/cdsco
Canonical HTML page: https://getbiobrief.com/entity/cdsco

## Timeline

- **2026-03-15T05:15:42Z**:  — Government expands Production Linked Incentives for high-end medical hardware.
- **2026-03-15T05:15:42Z**:  — Department of Commerce holds strategic session to strengthen the export ecosystem.
- **2026-02-22**: Formal Announcement — Official confirmation of the bilateral agreement to strengthen medical product regulation.
- **2026-02-21**: MoU Exchange Initiated — Initial diplomatic exchange of the regulatory cooperation framework in New Delhi.
- **2023-04-26**: National Medical Device Policy — Union Cabinet approves policy to facilitate orderly growth of the medical device sector.

## Recent coverage (3 stories)

### India Issues Regulatory Warning Over Misuse of Low-Cost Weight-Loss Injectables
2026-03-24 15:10:54 · Sentiment: Negative · Impact: 6/10 · Sources: 2

Indian health authorities have issued a formal warning regarding the rising misuse and health risks associated with affordable, non-regulated weight-loss injections. The move signals a tightening of oversight as the global demand for GLP-1 therapies triggers a surge in local compounding and unauthorized distribution.
Full story: https://getbiobrief.com/story/india-weight-loss-jab-warning-2026

### India Targets Global MedTech Leadership via Strategic Chintan Shivir
2026-03-15 05:15:42 · Sentiment: Positive · Impact: 6/10 · Sources: 4

The Indian Department of Commerce has convened a high-level Chintan Shivir to overhaul the nation's medical device export ecosystem. The initiative seeks to streamline regulatory frameworks and position India as a primary global manufacturing hub for high-end medical technology.
Full story: https://getbiobrief.com/story/india-medical-device-export-strategy-chintan-shivir

### India and Brazil Ink Strategic Regulatory Pact for Pharma and MedTech
2026-02-22 12:33:22 · Sentiment: Positive · Impact: 6/10 · Sources: 2

India and Brazil have formalized a Memorandum of Understanding (MoU) to harmonize regulatory standards for pharmaceutical and medical products. This bilateral agreement aims to streamline market access and enhance technical cooperation between two of the world's most influential emerging healthcare markets.
Full story: https://getbiobrief.com/story/india-brazil-pharma-regulatory-mou-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.